Bank of New York Mellon’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-867,706
| Closed | -$73.7M | – | 4257 |
|
|
2019
Q4 | $73.7M | Sell |
867,706
-50,192
| -5% | -$3.35M | 0.02% | 751 |
|
|
2019
Q3 | $45.9M | Buy |
917,898
+43,179
| +5% | +$1.72M | 0.01% | 998 |
|
|
2019
Q2 | $31.9M | Buy |
874,719
+93,781
| +12% | +$3.06M | 0.01% | 1252 |
|
|
2019
Q1 | $21.8M | Sell |
780,938
-4,645
| -0.6% | -$109K | 0.01% | 1494 |
|
|
2018
Q4 | $15M | Buy |
785,583
+13,303
| +2% | +$309K | ﹤0.01% | 1670 |
|
|
2018
Q3 | $23.1M | Buy |
772,280
+23,852
| +3% | +$899K | 0.01% | 1539 |
|
|
2018
Q2 | $27.5M | Sell |
748,428
-12,882
| -2% | -$419K | 0.01% | 1405 |
|
|
2018
Q1 | $25.1M | Buy |
761,310
+8,775
| +1% | +$274K | 0.01% | 1423 |
|
|
2017
Q4 | $20.6M | Sell |
752,535
-5,527
| -0.7% | -$170K | 0.01% | 1537 |
|
|
2017
Q3 | $28.1M | Sell |
758,062
-80,085
| -10% | -$2.95M | 0.01% | 1355 |
|
|
2017
Q2 | $31.9M | Sell |
838,147
-31,946
| -4% | -$1.42M | 0.01% | 1258 |
|
|
2017
Q1 | $42.5M | Buy |
870,093
+55,303
| +7% | +$2.52M | 0.01% | 1050 |
|
|
2016
Q4 | $27.7M | Sell |
814,790
-34,081
| -4% | -$1.21M | 0.01% | 1328 |
|
|
2016
Q3 | $32M | Buy |
848,871
+35,219
| +4% | +$1.33M | 0.01% | 1144 |
|
|
2016
Q2 | $27.4M | Sell |
813,652
-33,753
| -4% | -$1.19M | 0.01% | 1203 |
|
|
2016
Q1 | $26.9M | Buy |
847,405
+25,339
| +3% | +$828K | 0.01% | 1221 |
|
|
2015
Q4 | $30.7M | Buy |
822,066
+30,845
| +4% | +$1.17M | 0.01% | 1111 |
|
|
2015
Q3 | $30M | Buy |
791,221
+153,400
| +24% | +$5.38M | 0.01% | 1147 |
|
|
2015
Q2 | $18.2M | Buy |
637,821
+14,132
| +2% | +$394K | 0.01% | 1550 |
|
|
2015
Q1 | $17.5M | Sell |
623,689
-249,554
| -29% | -$7.01M | ﹤0.01% | 1602 |
|
|
2014
Q4 | $24.2M | Buy |
873,243
+1,031
| +0.1% | +$25.5K | 0.01% | 1328 |
|
|
2014
Q3 | $19.5M | Buy |
872,212
+11,829
| +1% | +$300K | 0.01% | 1444 |
|
|
2014
Q2 | $25M | Sell |
860,383
-4,426
| -0.5% | -$118K | 0.01% | 1329 |
|
|
2014
Q1 | $24.6M | Buy |
864,809
+278,145
| +47% | +$9.2M | 0.01% | 1336 |
|
|
2013
Q4 | $22.7M | Buy |
586,664
+9,123
| +2% | +$326K | 0.01% | 1382 |
|
|
2013
Q3 | $19.4M | Sell |
577,541
-51,177
| -8% | -$1.63M | 0.01% | 1429 |
|
|
2013
Q2 | $19.3M | Buy |
+628,718
| New | +$21M | 0.01% | 1394 |
|
Other funds holding MDCO
Bank of New York Mellon's MDCO Position: Q1 2020 in Review
Bank of New York Mellon sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 867,706 shares — an estimated $73.7M sold.
Bank of New York Mellon first reported a position in MDCO in Q2 2013 and held it in 27 quarters. The position peaked at $73.7M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Bank of New York Mellon reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Bank of New York Mellon sold 867,706 Medicines Co shares in Q1 2020, an estimated $73.7M.
- Bank of New York Mellon first reported a position in Medicines Co in Q2 2013 and held it in 27 quarters.
- Bank of New York Mellon's Medicines Co position peaked at $73.7M in Q4 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Bank of New York Mellon's 13F filing for Q1 2020, filed 6 May 2020.